Related to Oxford Medical Diagnostics to Offer V&F Mass Spec Technology in the U.K. and Ireland

• Danaher Snags Life Technologies’ MS Business and MDS Analytical Technologies for $1.1B
  
• Caprotec bioanalytics Opens U.S. Subsidiary to Exploit Capture Compound Mass Spec
  
• PerkinElmer Takes Over Danaher’s Share of JV in Inductively Coupled Plasma Mass Spectrometry
  
• AB Sciex and University of Geneva to Fine-Tune Processes for Mass Spectrometer that Combines Qualitative and Quantitative Analysis
  
• Biocrates and Chenomx to Co-Market MS and NMR-Based Metabolomics Technologies
  
• Bruker to Buy Certain Varian Chromatography Product Lines from Agilent
  
• Bruker Sets Up Chemical Analysis Division
  
• OriGene and ISB to Generate PeptideAtlas and 5,000-Protein SRM/MRM Database
  
• Caprotec Secures €4M to Further Capture Compound Mass Spec Platform
  
• Stemina Taps Agilent Tools for Stem Cell Metabolite Biomarker Discovery
  
• Swiss ETH Institute and AB Sciex Partner to Develop Faster Metabolomics Methods
  
• Thermo Fisher Scientific Collaborates to Advance Biomarker Research in Japan
  
• AB Sciex Provides CDC with Access to MS System for Hormone Standardization Project
  
• PerkinElmer Continues OneSource Service Contract with Minerva
  
• Arup Labs Chooses Bruker’s MALDI Biotyper for Microbial Identification Services
  
• Bruker Daltonics Chosen to Build World’s First 21.0 Tesla FT-ICR Magnet
  
• Waters Establishes Centers of Innovation Program
  
• AB Sciex Bolsters Presence in Korea
  
• Icon Expands Biomarker Services through Deal with Proteome Sciences
  
• Arup and AB Sciex Ally to Develop Methods for Hormone Analysis